$HZNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Horizon Therapeutics Public Ltd Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Horizon Therapeutics Public Ltd Co. Get notifications about new insider transactions in Horizon Therapeutics Public Ltd Co for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 12 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 125,000 | 0 | 899,621 | 774.6 K to 899.6 K (+16.14 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 104,431 | 108.6 K to 104.4 K (-3.87 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 104,431 | 108.6 K to 104.4 K (-3.87 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 9,500 | 0 | 108,640 | 99.1 K to 108.6 K (+9.58 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 9,500 | 0 | 108,640 | 99.1 K to 108.6 K (+9.58 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Option Exercise | M | 0.00 | 6,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Option Exercise | M | 0.00 | 6,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Payment of Exercise | F | 26.84 | 2,880 | 77,299 | 105,580 | 108.5 K to 105.6 K (-2.66 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Payment of Exercise | F | 26.84 | 2,880 | 77,299 | 105,580 | 108.5 K to 105.6 K (-2.66 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Buy | M | 0.00 | 6,500 | 0 | 108,460 | 102 K to 108.5 K (+6.38 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Kent Jeff | See remarks | Buy | M | 0.00 | 6,500 | 0 | 108,460 | 102 K to 108.5 K (+6.38 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 68,154 | 72.4 K to 68.2 K (-5.82 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 68,154 | 72.4 K to 68.2 K (-5.82 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 9,500 | 0 | 72,363 | 62.9 K to 72.4 K (+15.11 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 9,500 | 0 | 72,363 | 62.9 K to 72.4 K (+15.11 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 199,626 | 213.4 K to 199.6 K (-6.44 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 199,626 | 213.4 K to 199.6 K (-6.44 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 31,000 | 0 | 213,359 | 182.4 K to 213.4 K (+17.00 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 31,000 | 0 | 213,359 | 182.4 K to 213.4 K (+17.00 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 17,267 | 31 K to 17.3 K (-44.30 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 26.84 | 13,733 | 368,594 | 17,267 | 31 K to 17.3 K (-44.30 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 31,000 | 0 to 31 K |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 31,000 | 0 to 31 K |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 104,707 | 108.9 K to 104.7 K (-3.86 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 104,707 | 108.9 K to 104.7 K (-3.86 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 9,500 | 0 | 108,916 | 99.4 K to 108.9 K (+9.56 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 9,500 | 0 | 108,916 | 99.4 K to 108.9 K (+9.56 %) |
| Feb 25 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 21.26 | 2,000 | 42,520 | 28,867 | 30.9 K to 28.9 K (-6.48 %) |
| Feb 25 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 21.19 | 4,500 | 95,355 | 30,867 | 35.4 K to 30.9 K (-12.72 %) |
| Feb 25 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 21.20 | 3,580 | 75,896 | 35,367 | 38.9 K to 35.4 K (-9.19 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Option Exercise | M | 0.00 | 2,182 | 0 | 4,363 | |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Payment of Exercise | F | 21.24 | 1,082 | 22,982 | 30,596 | 31.7 K to 30.6 K (-3.42 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Buy | M | 0.00 | 2,182 | 0 | 31,678 | 29.5 K to 31.7 K (+7.40 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Payment of Exercise | F | 21.54 | 9,429 | 203,101 | 29,496 | 38.9 K to 29.5 K (-24.22 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Grant | A | 0.00 | 19,014 | 0 | 38,925 | 19.9 K to 38.9 K (+95.49 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 21.54 | 8,425 | 181,475 | 107,857 | 116.3 K to 107.9 K (-7.25 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Grant | A | 0.00 | 19,014 | 0 | 116,282 | 97.3 K to 116.3 K (+19.55 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 21.54 | 8,622 | 185,718 | 62,863 | 71.5 K to 62.9 K (-12.06 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Grant | A | 0.00 | 19,014 | 0 | 71,485 | 52.5 K to 71.5 K (+36.24 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 21.54 | 8,425 | 181,475 | 99,416 | 107.8 K to 99.4 K (-7.81 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Grant | A | 0.00 | 19,014 | 0 | 107,841 | 88.8 K to 107.8 K (+21.41 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Payment of Exercise | F | 21.54 | 4,179 | 90,016 | 38,947 | 43.1 K to 38.9 K (-9.69 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Grant | A | 0.00 | 14,259 | 0 | 43,126 | 28.9 K to 43.1 K (+49.40 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Payment of Exercise | F | 21.54 | 8,425 | 181,475 | 28,805 | 37.2 K to 28.8 K (-22.63 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Grant | A | 0.00 | 19,014 | 0 | 37,230 | 18.2 K to 37.2 K (+104.38 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Payment of Exercise | F | 21.54 | 15,795 | 340,224 | 47,531 | 63.3 K to 47.5 K (-24.94 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Grant | A | 0.00 | 35,652 | 0 | 63,326 | 27.7 K to 63.3 K (+128.83 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 21.54 | 32,064 | 690,659 | 182,359 | 214.4 K to 182.4 K (-14.95 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Grant | A | 0.00 | 72,375 | 0 | 214,423 | 142 K to 214.4 K (+50.95 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 21.54 | 32,064 | 690,659 | 40,311 | 72.4 K to 40.3 K (-44.30 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Grant | A | 0.00 | 72,375 | 0 | 72,375 | 0 to 72.4 K |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 21.54 | 74,657 | 1,608,112 | 774,621 | 849.3 K to 774.6 K (-8.79 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Grant | A | 0.00 | 168,521 | 0 | 849,278 | 680.8 K to 849.3 K (+24.75 %) |
| Feb 05 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 23.20 | 1,335 | 30,972 | 28,867 | 30.2 K to 28.9 K (-4.42 %) |
| Feb 05 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 23.25 | 2,000 | 46,500 | 30,202 | 32.2 K to 30.2 K (-6.21 %) |
| Feb 05 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Sell | S | 23.11 | 5,500 | 127,087 | 32,202 | 37.7 K to 32.2 K (-14.59 %) |
| Feb 01 2019 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | A | 0.00 | 27,260 | 0 | 27,260 | |
| Jan 23 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 12.19 | 16,406 | 199,989 | 24,188 | |
| Jan 23 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 12.19 | 16,406 | 199,989 | 24,188 | |
| Jan 23 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 12.19 | 16,406 | 199,989 | 99,140 | 82.7 K to 99.1 K (+19.83 %) |
| Jan 23 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 12.19 | 16,406 | 199,989 | 99,140 | 82.7 K to 99.1 K (+19.83 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 6,700 | 0 | 13,400 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 6,700 | 0 | 13,400 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | A | 0.00 | 26,974 | 0 | 26,974 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | A | 0.00 | 26,974 | 0 | 26,974 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 20.39 | 3,312 | 67,532 | 82,734 | 86 K to 82.7 K (-3.85 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 20.39 | 3,312 | 67,532 | 82,734 | 86 K to 82.7 K (-3.85 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 6,700 | 0 | 86,046 | 79.3 K to 86 K (+8.44 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 6,700 | 0 | 86,046 | 79.3 K to 86 K (+8.44 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Option Exercise | A | 0.00 | 36,782 | 0 | 36,782 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Option Exercise | A | 0.00 | 36,782 | 0 | 36,782 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Payment of Exercise | F | 20.39 | 8,931 | 182,103 | 19,911 | 28.8 K to 19.9 K (-30.97 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Payment of Exercise | F | 20.39 | 8,931 | 182,103 | 19,911 | 28.8 K to 19.9 K (-30.97 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Buy | M | 0.00 | 17,259 | 0 | 28,842 | 11.6 K to 28.8 K (+149.00 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | DesJardin Michael A. | EVP, Technical Oper ... | Buy | M | 0.00 | 17,259 | 0 | 28,842 | 11.6 K to 28.8 K (+149.00 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Option Exercise | M | 0.00 | 12,944 | 0 | 25,890 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Option Exercise | M | 0.00 | 12,944 | 0 | 25,890 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Option Exercise | A | 0.00 | 36,782 | 0 | 36,782 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Option Exercise | A | 0.00 | 36,782 | 0 | 36,782 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Payment of Exercise | F | 20.39 | 4,109 | 83,783 | 37,702 | 41.8 K to 37.7 K (-9.83 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Payment of Exercise | F | 20.39 | 4,109 | 83,783 | 37,702 | 41.8 K to 37.7 K (-9.83 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Buy | M | 0.00 | 12,944 | 0 | 41,811 | 28.9 K to 41.8 K (+44.84 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | EVP, Corporate Affa ... | Buy | M | 0.00 | 12,944 | 0 | 41,811 | 28.9 K to 41.8 K (+44.84 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Option Exercise | A | 0.00 | 36,782 | 0 | 36,782 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Option Exercise | A | 0.00 | 36,782 | 0 | 36,782 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 18,216 | 26.2 K to 18.2 K (-30.41 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 18,216 | 26.2 K to 18.2 K (-30.41 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Buy | M | 0.00 | 17,259 | 0 | 26,178 | 8.9 K to 26.2 K (+193.51 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Konstantinovsky Irina | EVP, Chief Human Re ... | Buy | M | 0.00 | 17,259 | 0 | 26,178 | 8.9 K to 26.2 K (+193.51 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | A | 0.00 | 36,782 | 0 | 36,782 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | A | 0.00 | 36,782 | 0 | 36,782 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 88,827 | 96.8 K to 88.8 K (-8.23 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 88,827 | 96.8 K to 88.8 K (-8.23 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 17,259 | 0 | 96,789 | 79.5 K to 96.8 K (+21.70 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 17,259 | 0 | 96,789 | 79.5 K to 96.8 K (+21.70 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 52,471 | 60.4 K to 52.5 K (-13.17 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 52,471 | 60.4 K to 52.5 K (-13.17 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 17,259 | 0 | 60,433 | 43.2 K to 60.4 K (+39.98 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 17,259 | 0 | 60,433 | 43.2 K to 60.4 K (+39.98 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | A | 0.00 | 73,948 | 0 | 73,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | A | 0.00 | 73,948 | 0 | 73,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 97,268 | 105.2 K to 97.3 K (-7.57 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 97,268 | 105.2 K to 97.3 K (-7.57 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Buy | M | 0.00 | 17,259 | 0 | 105,230 | 88 K to 105.2 K (+19.62 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Buy | M | 0.00 | 17,259 | 0 | 105,230 | 88 K to 105.2 K (+19.62 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Option Exercise | M | 0.00 | 32,362 | 0 | 64,725 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Option Exercise | M | 0.00 | 32,362 | 0 | 64,725 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Option Exercise | M | 0.00 | 17,891 | 0 | 53,676 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Option Exercise | M | 0.00 | 17,891 | 0 | 53,676 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Payment of Exercise | F | 20.39 | 14,337 | 292,331 | 27,674 | 42 K to 27.7 K (-34.13 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Payment of Exercise | F | 20.39 | 14,337 | 292,331 | 27,674 | 42 K to 27.7 K (-34.13 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Buy | M | 0.00 | 32,362 | 0 | 42,011 | 9.6 K to 42 K (+335.39 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Buy | M | 0.00 | 32,362 | 0 | 42,011 | 9.6 K to 42 K (+335.39 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Payment of Exercise | F | 20.39 | 8,242 | 168,054 | 9,649 | 17.9 K to 9.6 K (-46.07 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Payment of Exercise | F | 20.39 | 8,242 | 168,054 | 9,649 | 17.9 K to 9.6 K (-46.07 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Buy | M | 0.00 | 17,891 | 0 | 17,891 | 0 to 17.9 K |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D an ... | Buy | M | 0.00 | 17,891 | 0 | 17,891 | 0 to 17.9 K |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 65,695 | 0 | 131,392 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 65,695 | 0 | 131,392 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 20.39 | 29,419 | 599,853 | 36,276 | 65.7 K to 36.3 K (-44.78 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 20.39 | 29,419 | 599,853 | 36,276 | 65.7 K to 36.3 K (-44.78 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 65,695 | 0 | 65,695 | 0 to 65.7 K |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 65,695 | 0 | 65,695 | 0 to 65.7 K |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 65,695 | 0 | 131,392 |